Donald DeGolyer - Endo International Insider

Endo International plc -- USA Stock  

USD 6.71  0.30  4.28%

Special Advisor to the CEO

Mr. Donald W. Degolyer is a Chief Operating Officer Pharmaceuticals.
Age: 53        
353 1 268 2000

Donald DeGolyer Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.04 % which means that it generated profit of $3.04 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of (77.37) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 8.31 B in liabilities. Endo International plc has Current Ratio of 1.0 suggesting that it is not liquid enough and may have problems to pay out its financial obligations when they are due.

Similar Executives

Found 1 records

CEO Since

Brenton SaundersAllergan plc

Entity Summary

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug Manufacturers - Other classification in USA and traded on NASDAQ exchange. It employs 30 people.Endo International plc (ENDP) is traded on NASDAQ in USA. It is located in IRELAND and employs 3,039 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Endo International plc to your portfolio

Top Management

Endo International plc Leadership Team
Daniel Rudio, President
Camille Farhat, President, MBA
Paul Campanelli, CEO
William Spengler, Director
Arthur Higgins, Director
Brian Lortie, President
Donald DeGolyer, CEO
William Montague, Director
Jill Smith, Director
Rajiv Silva, CEO
Michael Hyatt, Director
Douglas Ingram, Director
Antonio Pera, President, MBA
Roger Kimmel, Chairman
Susan Hall, EVP, Ph.D
Sharad Mansukani, Director
Blaise Coleman, President, MBA
Suketu Upadhyay, CFO, CPA
Terrance Coughlin, President
Nancy Hutson, Director
Todd Sisitsky, Director, MBA
Matthew Maletta, President
Shane Cooke, Director
Craig Paterson, Executive, MBA

Stock Performance

Endo International Performance Indicators